Seller record · Telehealth service

Alinwell

Fails 2 of 8 criteria. S3, pharmacy identification: The site names no filling pharmacy; its pages say only partner compounding pharmacies in the United States. The published certificates of analysis are issued to Emerald Compounding Pharmacy in Tampa, Florida and Boudreaux's New Drug Store in Lake Charles, Louisiana, and no page presents either as the pharmacy that fills orders. 1 more criterion also fails; see the table below.

At a glance

AlinwellTelehealth service

6/8criteria passed
Price
Semaglutide from $139 a month, tirzepatide from $166
Sells
compounded semaglutide, compounded tirzepatide, GLP-1 microdose, and 5 more
FDA letters
None on file
Visit AlinwellSee all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A women's telehealth service selling compounded semaglutide and tirzepatide, a GLP-1 microdose program and oral GLP-1, with tesamorelin, sermorelin, NAD+ and PT-141 on its peptides page. It publishes certificates of analysis for four semaglutide and tirzepatide lots, and its privacy policy prints a placeholder address.

Operating entity Alinwell, LLC

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSAlinwell's website; Alinwell's sermorelin product page
S2Prescription gatingPASSAlinwell's eligibility page; Alinwell's website
S3Pharmacy identificationFAILAlinwell's NAD+ product page; Alinwell's COA semaglutide 4mg document; Alinwell's COA semaglutide 2 5mg document
S4Compounding disclosurePASSAlinwell's website; Alinwell's semaglutide product page
S5Analytical documentationPASSAlinwell's COA semaglutide 4mg document; Alinwell's COA semaglutide 2 5mg document; Alinwell's COA tirzepatide 10mg document; Alinwell's COA tirzepatide 20mg document
S6Business addressFAILAlinwell's contact page; Alinwell's privacy page
S7Price disclosurePASSAlinwell's website; Alinwell's peptides page
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed provider reviews every order and prescribes only if it is clinically appropriate, and licensed providers shape every dosing decision.Source: Alinwell's website; Alinwell's sermorelin product page.
S2PASSThe check eligibility button opens an intake whose first screen asks what the patient wants support with, and the site has no cart. The home page states that the charge is $0 if the patient is not approved.Source: Alinwell's eligibility page; Alinwell's website.
S3FAILThe site names no filling pharmacy; its pages say only partner compounding pharmacies in the United States. The published certificates of analysis are issued to Emerald Compounding Pharmacy in Tampa, Florida and Boudreaux's New Drug Store in Lake Charles, Louisiana, and no page presents either as the pharmacy that fills orders.Source: Alinwell's NAD+ product page; Alinwell's COA semaglutide 4mg document; Alinwell's COA semaglutide 2 5mg document.
S4PASSCompounded medications are not FDA-approved and their safety, efficacy, and quality have not been independently verified by the FDA, printed on every page, and the home page adds that compounded semaglutide and tirzepatide are not the same as the branded medications.Source: Alinwell's website; Alinwell's semaglutide product page.
S5PASSFour certificates of analysis are published as documents, two for semaglutide and two for tirzepatide, each naming a lot number and a measured potency, linked from the semaglutide and tirzepatide pages.Source: Alinwell's COA semaglutide 4mg document; Alinwell's COA semaglutide 2 5mg document; Alinwell's COA tirzepatide 10mg document; Alinwell's COA tirzepatide 20mg document.
S6FAILAlinwell prints two different addresses for itself. The contact page gives Alinwell, LLC at 950 E. State Hwy 114, Suite 160, Southlake, TX 76092, while the privacy policy gives Alinwell LLC at 123 Example Street, Suite 100, Your City, WI, 92308, a placeholder.Source: Alinwell's contact page; Alinwell's privacy page.
S7PASSSemaglutide from $139 a month, the figure the site banner calls a new patient offer, tirzepatide from $166, the GLP-1 microdose from $149 and oral GLP-1 from $150. The peptides page prints tesamorelin from $299, sermorelin from $249, NAD+ from $199 and PT-141 from $249, while the home page prints sermorelin from $349 and NAD+ from $249.Source: Alinwell's website; Alinwell's peptides page.
S8PASSNo FDA warning letter names Alinwell or Alinwell, LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, GLP-1 microdose, oral GLP-1, compounded tesamorelin, sermorelin, NAD+, PT-141.

Unpaid link. Alinwell does not pay the site, and nothing is earned when it is used. Funding.

Visit Alinwell

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.